You are here: Industry Insights > Medtronic

News List

Arcutis Announces Additions to its Investor Relations and Communications Team firstwordpharma
August 03, 2021
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company,today announced leadership additions to investor relations and communications functions.
Medtronic, Novo Nordisk to develop digital solutions for Diabetes biospectrumasia
September 16, 2019
Diabetes is a time-intensive disease that requires daily decisions about blood glucose monitoring, nutrition, insulin and drug intake.
Medtronic welcomes new CEO biospectrumasia
August 29, 2019
Medtronic has announced that Omar Ishrak, Medtronic's Chairman and Chief Executive Officer (CEO), has announced his intention to retire as CEO on April 26, 2020, following the end of the company's current fiscal year.
Medtronic Evolut TAVR System receives expanded indication biospectrumasia
August 20, 2019
Expanded TAVR Indication to Younger, More Active Patients Signals Groundbreaking Shift in the Future Treatment of Heart Valve Disease
Medtronic Recalls Some Insulin Pumps as FDA Warns They Could Be Hacked drugs
July 01, 2019
Medtronic Recalls Some Insulin Pumps as FDA Warns They Could Be Hacked.
Medtronic Recalls Some Insulin Pumps Over Cybersecurity Concerns drugs
July 01, 2019
Medtronic Recalls Some Insulin Pumps Over Cybersecurity Concerns.
Philips announces collaboration with Medtronic biospectrumasia
May 15, 2019
Philips will bring to market the novel KODEX-EPD cardiac imaging and navigation system with cryoablation specific features
Medtronic launches ‘brain pacemaker’ implant for reducing epileptic seizures fiercebiotech
February 22, 2019
By delivering controlled electrical pulses to a portion of the brain linked to memory and alertness—and which forms part of a network involved in seizures—Medtronic aims to ....
Medtronic to pay $51M to settle DOJ claims against its Covidien and ev3 acquisitions fiercebiotech
December 29, 2018
Medtronic has agreed to pay nearly $51 million to settle claims against two of its more recent acquisitions—Covidien and ev3—related to the promotion of a medical device for unapproved use, as well as an alleged system of kickbacks for another device.....
Medtronic introduces IN.PACT Admiral DCB in Japan biospectrumasia
August 20, 2018
IN.PACT Admiral DCB is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reduces interventions, and preserves future treatment options.

Previous page 1 2 Next page